73

Oncology
Prevention and treatment of tumors, and caring for cancer patients.
Sub Categories on Oncology
Latest Articles
Engineered receptors help the immune system home in on cancer

Engineered receptors help the immune system home in on cancer

byUniversity of California, San FranciscoCredit: CC0 Public DomainMost cancer treatments—from chemotherapies to engineered immune cells—have a host of side effects, in large part because they af

Engineered receptors help the immune system home in on cancer

byUniversity of California, San FranciscoCredit: CC0 Public DomainMost cancer treatments—from chemotherapies to engineered immune cells—have a host of side effects, in large part because they af
Better adenoma detection using a molecular marker for fluorescent imaging

Better adenoma detection using a molecular marker for fluorescent imaging

by Sarah E. Glass,Vanderbilt University(a)Representative white light and corresponding fluorescence colonoscopy images (static) of B6;129 mice bearing either colorectal adenomas or normal

Better adenoma detection using a molecular marker for fluorescent imaging

by Sarah E. Glass,Vanderbilt University(a)Representative white light and corresponding fluorescence colonoscopy images (static) of B6;129 mice bearing either colorectal adenomas or normal
Optimizing tobacco cessation treatment with lung cancer screening

Optimizing tobacco cessation treatment with lung cancer screening

byUniversity of MinnesotaVisual Abstract.Optimizing Longitudinal Tobacco Cessation Treatment in Lung Cancer Screening. Credit:JAMA Network Open(2023). DOI: 10.1001/jamanetworko

Optimizing tobacco cessation treatment with lung cancer screening

byUniversity of MinnesotaVisual Abstract.Optimizing Longitudinal Tobacco Cessation Treatment in Lung Cancer Screening. Credit:JAMA Network Open(2023). DOI: 10.1001/jamanetworko
Existing cancer drugs have potential to benefit thousands more patients, research shows

Existing cancer drugs have potential to benefit thousands more patients, research shows

byInstitute of Cancer ResearchSF3B1 hotspot mutations confer sensitivity to PARP inhibition by eliciting a defective replication stress response. Credit:Nature Genetics(2023). DOI: 1

Existing cancer drugs have potential to benefit thousands more patients, research shows

byInstitute of Cancer ResearchSF3B1 hotspot mutations confer sensitivity to PARP inhibition by eliciting a defective replication stress response. Credit:Nature Genetics(2023). DOI: 1
Genetic discovery paves the way for advanced pancreatic and colorectal cancer treatments

Genetic discovery paves the way for advanced pancreatic and colorectal cancer treatments

byUniversity of HelsinkiWild-type Kras deficient KPN cells show reduced metastatic capacity and increased immune infiltration. Credit:Nature Communications(2024). DOI: 10.1038/s41467

Genetic discovery paves the way for advanced pancreatic and colorectal cancer treatments

byUniversity of HelsinkiWild-type Kras deficient KPN cells show reduced metastatic capacity and increased immune infiltration. Credit:Nature Communications(2024). DOI: 10.1038/s41467
Biosensors for bladder cancer diagnosis

Biosensors for bladder cancer diagnosis

by University of BathCredit: AI-generated imageCancer constitutes one of the leading causes of mortality worldwide. As early diagnosis is paramount to improved clinical outcome and survival, sens

Biosensors for bladder cancer diagnosis

by University of BathCredit: AI-generated imageCancer constitutes one of the leading causes of mortality worldwide. As early diagnosis is paramount to improved clinical outcome and survival, sens
Potent results from a new immune treatment seen in patients with hard-to-treat blood cancers

Potent results from a new immune treatment seen in patients with hard-to-treat blood cancers

by Peter MacCallum Cancer CentreCredit: Pixabay/CC0 Public DomainAll patients in the Phase I / II clinical trial of glofitamab had Diffuse Large B-Cell Lymphoma (DLBCL) and their cancer had relapsed o

Potent results from a new immune treatment seen in patients with hard-to-treat blood cancers

by Peter MacCallum Cancer CentreCredit: Pixabay/CC0 Public DomainAll patients in the Phase I / II clinical trial of glofitamab had Diffuse Large B-Cell Lymphoma (DLBCL) and their cancer had relapsed o
Specifically designed diets demonstrate a 'powerful ability' to prevent tumorigenesis, delay tumor growth

Specifically designed diets demonstrate a 'powerful ability' to prevent tumorigenesis, delay tumor growth

byThe Spanish National Cancer Research CentrePrecision nutrition in cancer therapyPrecision nutrition takes into account genetic, physiological and lifestyle factors to develop personalized diet

Specifically designed diets demonstrate a 'powerful ability' to prevent tumorigenesis, delay tumor growth

byThe Spanish National Cancer Research CentrePrecision nutrition in cancer therapyPrecision nutrition takes into account genetic, physiological and lifestyle factors to develop personalized diet
Breast cancer test could guide treatment for more aggressive subtype

Breast cancer test could guide treatment for more aggressive subtype

byInstitute of Cancer ResearchKi67 changes from baseline to surgery stratified by intrinsic subtype at baseline within a. Treated and b. Controls. Abbreviations: HER2-E, HER2-Enriched Subtype; L

Breast cancer test could guide treatment for more aggressive subtype

byInstitute of Cancer ResearchKi67 changes from baseline to surgery stratified by intrinsic subtype at baseline within a. Treated and b. Controls. Abbreviations: HER2-E, HER2-Enriched Subtype; L
Prostate cancer: Can AI help to avoid unnecessary biopsies?

Prostate cancer: Can AI help to avoid unnecessary biopsies?

byGerman Cancer Research CenterRisk stratification example from the test cohort: a 66-year-old male presents with negative DRE, PSA elevation to 6.2 ng/mL, prostate volume of 82.5 mL, and PSAD o

Prostate cancer: Can AI help to avoid unnecessary biopsies?

byGerman Cancer Research CenterRisk stratification example from the test cohort: a 66-year-old male presents with negative DRE, PSA elevation to 6.2 ng/mL, prostate volume of 82.5 mL, and PSAD o
Colorectal cancer 'not an old people's disease anymore'

Colorectal cancer 'not an old people's disease anymore'

by University of Washington School of MedicineCredit: CC0 Public DomainThere are two statistics that Dr. Rachel Issaka would like people to seriously consider:In the last 30 years, the incidence

Colorectal cancer 'not an old people's disease anymore'

by University of Washington School of MedicineCredit: CC0 Public DomainThere are two statistics that Dr. Rachel Issaka would like people to seriously consider:In the last 30 years, the incidence
Late effects of treatment hinder independence of adult survivors of childhood brain tumors

Late effects of treatment hinder independence of adult survivors of childhood brain tumors

by St. Jude Children's Research HospitalCorresponding author Tara Brinkman, PhD, and Gregory Armstrong, MD, MSCE, investigated six aspects of independence among St. Jude Lifetime Cohort parti

Late effects of treatment hinder independence of adult survivors of childhood brain tumors

by St. Jude Children's Research HospitalCorresponding author Tara Brinkman, PhD, and Gregory Armstrong, MD, MSCE, investigated six aspects of independence among St. Jude Lifetime Cohort parti